Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-24 · accession 0001415889-22-003396 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-28 | 2022-03-24 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +19.4K | 34.4K | +130% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | A | A | 19,428 | $0.00 | 34,378 | D | — | — |